Literature DB >> 21169891

Autistic spectrum disorders and schizophrenia in the adult psychiatric setting: diagnosis and comorbidity.

Michele Raja1, Antonella Azzoni.   

Abstract

BACKGROUND: The relationship between Autism Spectrum Disorders (ASDs) and schizophrenia is currently unclear. We aimed to (a) assess psychotic symptoms in a consecutive series of adult patients with ASDs, (b) evaluate the comorbidity diagnosed to account for the concurrent psychotic symptoms in patients with ASDs, and (c) compare the clinical features between the patients with schizophrenia and patients with comorbid schizophrenia and ASDs. SUBJECTS AND METHODS: We included patients with ASD that were seen in adult psychiatric clinical settings during a 15-year period. The sample was further grouped according to the existence of a comorbid diagnosis of schizophrenia. Clinical and epidemiological features were assesed in in the whole sample, and further compared between the two groups.
RESULTS: We identified 26 patients with first-time diagnosed ASDs. Among the 22 cases who manifested psychotic symptoms (84.6%), 16 had a concurrent diagnosis of schizophrenia (72.73%) and 6 of mood disorders (27.27%). Compared with patients with schizophrenia patients with comorbid ASDs and schizophrenia were more often men, of younger age, and more frequently developed motor side effects to antipsychotics.
CONCLUSIONS: Adult psychiatric service users with ASDs are often misdiagnosed. This could be in part due to the fact that adult psychiatrists are not familiar with the diagnosis of ASDs. The high prevalence of psychotic symptoms in this sample is likely to depend on the specific setting of the study, i.e., that people with more severe forms of ASD than those typically followed-up in the national health service were reaching our public inpatient and private outpatient services. The high comorbidity rate between ASDs and schizophrenia could be related to shared neurobiology, but also to arbitrary restrictions imposed by current diagnostic systems.

Entities:  

Mesh:

Year:  2010        PMID: 21169891

Source DB:  PubMed          Journal:  Psychiatr Danub        ISSN: 0353-5053            Impact factor:   1.063


  7 in total

1.  Psychosis in a Child with Atypical Autism: A Case Report and a Brief Review of the Association of Psychosis and Autism.

Authors:  Swapnajeet Sahoo; Susanta Kumar Padhy; Neha Singla; Aakanksha Singh
Journal:  Innov Clin Neurosci       Date:  2018-04-01

2.  An autism dimension for schizophrenia in the next Diagnostic and Statistical Manual?

Authors:  Andrea L Pelletier; Vijay A Mittal
Journal:  Schizophr Res       Date:  2012-02-18       Impact factor: 4.939

3.  The relationship between Asperger's syndrome and schizophrenia in adolescence.

Authors:  Petra Waris; Nina Lindberg; Kirsi Kettunen; Pekka Tani
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-10-13       Impact factor: 4.785

4.  Prevalence of Schizophrenia Spectrum Disorders in Average-IQ Adults with Autism Spectrum Disorders: A Meta-analysis.

Authors:  Jorge Lugo Marín; Montserrat Alviani Rodríguez-Franco; Vinita Mahtani Chugani; María Magán Maganto; Emiliano Díez Villoria; Ricardo Canal Bedia
Journal:  J Autism Dev Disord       Date:  2018-01

5.  Clinical Usefulness of Aripiprazole and Lamotrigine in Schizoaffective Presentation of Tuberous Sclerosis.

Authors:  Seung-Yup Lee; Jung-Ah Min; In Goo Lee; Jung Jin Kim
Journal:  Clin Psychopharmacol Neurosci       Date:  2016-08-31       Impact factor: 2.582

Review 6.  Prevalence of Non-Affective Psychoses in Individuals with Autism Spectrum Disorders: A Systematic Review.

Authors:  Riccardo De Giorgi; Franco De Crescenzo; Gian Loreto D'Alò; Nicola Rizzo Pesci; Valeria Di Franco; Corrado Sandini; Marco Armando
Journal:  J Clin Med       Date:  2019-08-24       Impact factor: 4.241

7.  A symptom-based approach to treatment of psychosis in autism spectrum disorder [corrected].

Authors:  Victoria Bell; Henry Dunne; Tharun Zacharia; Katrina Brooker; Sukhi Shergill
Journal:  BJPsych Open       Date:  2018-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.